Recurrence Rate at 5 y | Effect on graft* | Treatment | |
---|---|---|---|
*−, no effect on graft survival; +/−, rarely affects graft survival; +, occasionally affects graft survival; +++, usually reduces graft survival. | |||
†Transplantation does not cure haemochromatosis. | |||
PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; AIH, autoimmune hepatitis; HCC, hepatocellular carcinoma; CCA, choangiocarcinoma; UDCA, ursodeoxycholic acid; IFN, interferon; Riba, ribavirin. | |||
Autoimmune | |||
PBC | 25% | +/− | ?UDCA |
PSC | 50% | ++ | Uncertain |
AIH | 10% | + | Steroids |
Viral | |||
Hepatitis A | N/A | − | Nil |
Hepatitis B | Variable | + | Lamuvidine |
Hepatitis C | 85% | ++ | IFN+Riba |
Cancer | |||
HCC | Variable | Variable | Nil |
CCA | High | +++ | Nil |
Metabolic | |||
Haemochromatosis | High† | +/− | Venesection |